Serena Giuntini

579 total citations
20 papers, 471 citations indexed

About

Serena Giuntini is a scholar working on Microbiology, Epidemiology and Immunology. According to data from OpenAlex, Serena Giuntini has authored 20 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Microbiology, 15 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Serena Giuntini's work include Bacterial Infections and Vaccines (17 papers), Pneumonia and Respiratory Infections (13 papers) and Complement system in diseases (6 papers). Serena Giuntini is often cited by papers focused on Bacterial Infections and Vaccines (17 papers), Pneumonia and Respiratory Infections (13 papers) and Complement system in diseases (6 papers). Serena Giuntini collaborates with scholars based in United States, Italy and Peru. Serena Giuntini's co-authors include Dan M. Granoff, Donald C. Reason, Peter T. Beernink, Anja Seubert, Oliver Koeberling, Sanjay Ram, Rolando Pajón, David M. Vu, Elizabeth Partridge and Raffaella Rossi and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Serena Giuntini

19 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serena Giuntini United States 16 368 300 130 75 59 20 471
Oliver Koeberling Italy 12 547 1.5× 479 1.6× 127 1.0× 63 0.8× 41 0.7× 14 604
Leena Saarinen Finland 15 350 1.0× 392 1.3× 107 0.8× 51 0.7× 64 1.1× 19 533
B. Danve France 12 487 1.3× 382 1.3× 54 0.4× 87 1.2× 44 0.7× 15 619
George França dos Santos United States 11 627 1.7× 600 2.0× 114 0.9× 50 0.7× 28 0.5× 19 714
Jutamas Shaughnessy United States 20 529 1.4× 350 1.2× 321 2.5× 139 1.9× 53 0.9× 34 814
K A Warren United States 7 192 0.5× 115 0.4× 106 0.8× 50 0.7× 38 0.6× 8 324
L van Alphen Netherlands 9 382 1.0× 333 1.1× 72 0.6× 29 0.4× 152 2.6× 14 572
Leah Fletcher United States 8 290 0.8× 327 1.1× 95 0.7× 75 1.0× 16 0.3× 10 485
James Wassil United States 9 308 0.8× 306 1.0× 33 0.3× 43 0.6× 17 0.3× 13 441
Philip Barren United States 6 250 0.7× 356 1.2× 65 0.5× 69 0.9× 21 0.4× 6 553

Countries citing papers authored by Serena Giuntini

Since Specialization
Citations

This map shows the geographic impact of Serena Giuntini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Giuntini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Giuntini more than expected).

Fields of papers citing papers by Serena Giuntini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Giuntini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Giuntini. The network helps show where Serena Giuntini may publish in the future.

Co-authorship network of co-authors of Serena Giuntini

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Giuntini. A scholar is included among the top collaborators of Serena Giuntini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Giuntini. Serena Giuntini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Amcheslavsky, Alla, Aaron Wallace, Monir Ejemel, et al.. (2021). Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design. Scientific Reports. 11(1). 2751–2751. 28 indexed citations
3.
Stoppato, Matteo, Carlos Gaspar, James Regeimbal, et al.. (2020). Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model. Vaccine. 38(10). 2333–2339. 18 indexed citations
4.
5.
Giuntini, Serena, Matteo Stoppato, Maja Sedic, et al.. (2018). Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection. Infection and Immunity. 86(8). 19 indexed citations
6.
Partridge, Elizabeth, et al.. (2017). Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp Vaccine. Clinical and Vaccine Immunology. 24(8). 20 indexed citations
7.
Partridge, Elizabeth, et al.. (2017). The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C. Vaccine. 35(33). 4236–4244. 15 indexed citations
8.
Granoff, Dan M., et al.. (2016). Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding. JCI Insight. 1(14). e88907–e88907. 25 indexed citations
9.
Partridge, Elizabeth, et al.. (2016). The Role of Antibodies to Neisserial Heparin Binding Antigen (NHba) in Protection Elicited by the GSK Serogroup B Meningococcal Vaccine (MenB-4C) Vaccine. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations
10.
Giuntini, Serena, Malick M. Gibani, Christina Dold, et al.. (2016). Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci. Clinical and Vaccine Immunology. 24(1). 25 indexed citations
11.
Rossi, Raffaella, Peter T. Beernink, Serena Giuntini, & Dan M. Granoff. (2015). Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine. Clinical and Vaccine Immunology. 22(12). 1227–1234. 22 indexed citations
12.
Beernink, Peter T., et al.. (2015). Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding Protein. mBio. 6(3). e00842–e00842. 13 indexed citations
13.
14.
Giuntini, Serena, Peter T. Beernink, & Dan M. Granoff. (2015). Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine. Vaccine. 33(51). 7168–7175. 16 indexed citations
15.
Giuntini, Serena, Rolando Pajón, Sanjay Ram, & Dan M. Granoff. (2015). Binding of Complement Factor H to PorB3 and NspA Enhances Resistance of Neisseria meningitidis to Anti-Factor H Binding Protein Bactericidal Activity. Infection and Immunity. 83(4). 1536–1545. 33 indexed citations
16.
Giuntini, Serena, David M. Vu, & Dan M. Granoff. (2013). fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations. Vaccine. 31(38). 4192–4199. 15 indexed citations
17.
Giuntini, Serena, Peter T. Beernink, Donald C. Reason, & Dan M. Granoff. (2012). Monoclonal Antibodies to Meningococcal Factor H Binding Protein with Overlapping Epitopes and Discordant Functional Activity. PLoS ONE. 7(3). e34272–e34272. 17 indexed citations
18.
Giuntini, Serena, Donald C. Reason, & Dan M. Granoff. (2011). Complement-Mediated Bactericidal Activity of Anti-Factor H Binding Protein Monoclonal Antibodies against the Meningococcus Relies upon Blocking Factor H Binding. Infection and Immunity. 79(9). 3751–3759. 59 indexed citations
19.
Giuntini, Serena, Donald C. Reason, & Dan M. Granoff. (2011). Combined Roles of Human IgG Subclass, Alternative Complement Pathway Activation, and Epitope Density in the Bactericidal Activity of Antibodies to Meningococcal Factor H Binding Protein. Infection and Immunity. 80(1). 187–194. 54 indexed citations
20.
Koeberling, Oliver, Serena Giuntini, Anja Seubert, & Dan M. Granoff. (2008). Meningococcal Outer Membrane Vesicle Vaccines Derived from Mutant Strains Engineered To Express Factor H Binding Proteins from Antigenic Variant Groups 1 and 2. Clinical and Vaccine Immunology. 16(2). 156–162. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver Koeberling Breakdown of academic impact, for papers by Leena Saarinen Breakdown of academic impact, for papers by B. Danve Breakdown of academic impact, for papers by George França dos Santos Breakdown of academic impact, for papers by Jutamas Shaughnessy Breakdown of academic impact, for papers by K A Warren Breakdown of academic impact, for papers by L van Alphen Breakdown of academic impact, for papers by Leah Fletcher Breakdown of academic impact, for papers by James Wassil Breakdown of academic impact, for papers by Philip Barren
Rankless by CCL
2026